KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Astrazeneca (AZN) Inventory Average (2016 - 2025)

Astrazeneca has reported Inventory Average over the past 10 years, most recently at $5.9 billion for Q4 2025.

  • Quarterly results put Inventory Average at $5.9 billion for Q4 2025, up 10.58% from a year ago — trailing twelve months through Dec 2025 was $5.9 billion (up 10.58% YoY), and the annual figure for FY2025 was $5.9 billion, up 10.58%.
  • Inventory Average for Q4 2025 was $5.9 billion at Astrazeneca, up from $5.4 billion in the prior quarter.
  • Over the last five years, Inventory Average for AZN hit a ceiling of $6.8 billion in Q4 2022 and a floor of $5.1 billion in Q4 2023.
  • Median Inventory Average over the past 5 years was $5.9 billion (2025), compared with a mean of $5.9 billion.
  • Biggest five-year swings in Inventory Average: surged 80.23% in 2021 and later dropped 26.01% in 2023.
  • Astrazeneca's Inventory Average stood at $6.5 billion in 2021, then rose by 5.19% to $6.8 billion in 2022, then dropped by 26.01% to $5.1 billion in 2023, then increased by 5.82% to $5.4 billion in 2024, then rose by 10.58% to $5.9 billion in 2025.
  • The last three reported values for Inventory Average were $5.9 billion (Q4 2025), $5.4 billion (Q4 2024), and $5.1 billion (Q4 2023) per Business Quant data.